Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823959) titled 'CBC-Based Inflammatory Indices in Newly Diagnosed Multiple Myeloma' on Sept. 11.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Multiple Myeloma
Recruitment Status: Not recruiting
Date of First Enrollment: October 2026
Target Sample Size: 60
To know more, visit https://clinicaltrials.gov/study/NCT07823959
Disclaimer: Curated by HT Syndication....